Saturday, July 2, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

by Medical Finance
in Coronavirus
Study: A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2. Image Credit: Sutthituch/Shutterstock
9
SHARES
103
VIEWS
Share on FacebookShare on Twitter

Furin is a protease enzyme that helps inactive proteins move to a biologically active state. In viruses, furin can cleave sites that help to make the virus more infectious.

A recent article, published in the journal Pharmacological Reports, suggests that coronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depend on a furin cleavage site between the S1/S2 subunits to enhance viral infectivity.

Study: A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2. Image Credit: Sutthituch/ShutterstockStudy: A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2. Image Credit: Sutthituch/Shutterstock

The authors argue that furin inhibitors are a potential tool for targeting a key player in SARS-CoV-2’s viral infection lifestyle. Doing so can significantly reduce the viral spread in human cells.

Role of furin and mechanism of action for viral infection

Most studies investigating SARS-CoV-2 infection look at the relationship between the spike protein and the ACE2 receptor as a point for viral entry. However, other human coronaviruses — human coronavirus 229E and dipeptidyl peptidase 4 — use aminopeptidase N as entry receptors. During infection, the spike protein is cut up into subunits S1 and S2 subunits.

Subunit S1has the receptor-binding domain that is used to bind ACE2. The process of cleaving glycoproteins and eventual binding may need the help of enzymes such as subtilisin-like endoproteases or trypsin endoproteases. One type of endoprotease is furins/proprotein convertase subtilisin/kexin proteins which are calcium-dependent and found in the human body.

Furin is a transmembrane that helps cleave the spike protein, which has helped respiratory viruses such as the Middle East respiratory syndrome coronavirus (MERS-CoV) turn inactive proteins into active ones that promote infection.

Through endosomal translocation, furin is expressed in the cell membrane and the trans-Golgi network. After cleavage, furin can be found as an active enzyme in the extracellular space.

Research has shown that SARS-CoV-2 has a cleavage site of four amino acids between the S1 and S2 subunit of the S glycoprotein — similar but not exact to the cleavage site seen in MERS-CoV.

The insert has a functional furin cleavage motif at the S1/S2 site, which may allude to an important role in SARS-CoV-2 viral entry into human cells. Although, the authors do note that furin is not essential for viral entry. The SARS-CoV-2 spike protein has more than one cleavage site and also depends on other proteases, such as transmembrane protease, serine 2 (TMPRSS2).

While SARS-CoV-2 does not need furin to carry out viral entry into host cells, it makes the cleavage process more efficient. Therefore, furin inhibitors may significantly reduce viral spread but not prevent it altogether.

Because other viruses besides SARS-CoV-2 rely on furin, a furin inhibitor could possess broad-spectrum antiviral effects.

Furin inhibitors for the potential treatment of COVID-19 infection

Given the importance of furin for optimizing viral infectivity processes, treatments targeting furin may help limit the spread of SARS-CoV-2. The researchers argue that furin antagonists could suppress infections two-fold. Not only would SARS-CoV-2 have a harder time getting into cells, it would also give the immune system more time to track down and eliminate the virus.

Non-peptide compounds, pure peptides, and peptides mimetics are able to inhibit furin could potentially be repurposed as a COVID-19 treatment. However, using peptides comes with certain disadvantages such as its limited absorption in the intestinal tract and the instability of free peptides.

Some macrocyclic peptidomimetic drugs are available and have been shown to block furin by binding to its active site. However, these drugs were not shown to inhibit viral replication.

Another peptidomemetic molecule called dec-RVKR-cmk is created from choromethyl keton and is a furin convertase inhibitor. They bind to the catalytic site and can stop the spread of viruses that depend on furin for infectivity. Chemical modifications to this furin inhibitor such as changing the C-terminal with decarboxylated arginine mimetics may enhance its effectiveness.

Furin relies on the specific amino acid side chain in the cleavage site. Understanding that furin needs an arginine residue in P1 and at least two residues of arginine and lysine in positions P2, P4, and P6 could help in designing potent protein-based inhibitors.

Beyond proteins and peptides, small molecule-based competitive furin inhibitors are available and do not have any stability issues.

Furin is negatively charged so having positively charged inhibitors such as Guanidinylated Aryl 2,5-Dideoxystreptamine Derivatives (GADDs) could promote antiviral effects.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study. Image Credit: NIAID

More evidence that pediatric COVID vaccination prevents MIS-C

by Medical Finance
July 2, 2022
0

Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of coronavirus disease 2019 (COVID-19) pandemic, does not affect children...

Study: Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Image Credit: ker_vii / Shutterstock

Remdesivir shows no significant effect on patients with COVID-19 in Solidarity trial

by Medical Finance
July 2, 2022
0

Even as the coronavirus disease 2019 (COVID-19) continues to cause thousands of new cases and dozens of deaths each day,...

Report: Global excess deaths associated with COVID-19, January 2020 - December 2021. Image Credit: VK Studio / Shutterstock

About 15 million additional deaths attributed to COVID-19 between January 2020 and December 2021

by Medical Finance
July 2, 2022
0

The World Health Organization (WHO) has released new figures showing that the coronavirus disease 2019 (COVID-19) pandemic caused almost 15...

Study: Risk of Myocarditis and Pericarditis Following BNT162b2 and mRNA-1273 COVID-19 Vaccination. Image Credit: Teeradej / Shutterstock.com

Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines

by Medical Finance
July 2, 2022
0

Several messenger ribonucleic acid (mRNA) vaccines have been developed to combat the ongoing coronavirus disease 2019 (COVID-19) pandemic, of which...

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

Alcohol use decreases steadily among men, but problem drinking increases during the pandemic

by Medical Finance
July 2, 2022
0

Alcohol consumption during the coronavirus pandemic declined among men, while it remained steady among women, according to a new RAND...

Study: The Global case-fatality rate of COVID-19 has been declining disproportionately between top vaccinated countries and the rest of the world. Image Credit: Syda Productions/Shutterstock

Study suggests COVID-19 patient fatalities are decreasing unequally in vaccinated and unvaccinated countries

by Medical Finance
July 2, 2022
0

The coronavirus disease 2019 (COVID-19) pandemic has spread to nearly every country in the world and caused over 5.5 million...

Next Post
Small cluster of neurons in the brain stem found to coordinate vocalization with breathing

NUS researchers discover a new way to interpret unsolved Mendelian diseases

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Online version of algorithm shows how biases in RNA sequences affect gene expression

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses. Image Credit: Corona Borealis Studio/Shutterstock
    Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy
  • Study: Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine. Image Credit: cortex-film/Shutterstock
    Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply